Federal proposals and recent administrative moves are reshaping how federally funded science would be reviewed and conducted, prompting alarm among researchers who say the changes could make it onerous to carry out government-supported research.
New OMB rules would expand political oversight
In May, the Office of Management and Budget released a set of proposed revisions to the Code of Federal Regulations governing grants and federal financial assistance. The changes would introduce new layers of oversight and alter long-standing practices for peer review and award decisions.
Among the alterations spelled out in the proposal are requirements that grant applications be evaluated for how they align with the president’s policy priorities, and provisions allowing political appointees greater authority to review and overturn award recommendations historically made through scientific peer review.
Researchers warn of chilling effects
Scientists and advocates say the combination of grant freezes, administrative disruptions at agencies such as the National Institutes of Health, new political reviews hunting for disfavored keywords like "disparity" and "marginalized," and the OMB rules together point toward a research environment that could become increasingly difficult to navigate.
- Grant freezes and operational disarray at federal funding agencies have already disrupted grant processes.
- New review layers would permit political appointees to scrutinize and potentially reverse scientific funding decisions.
- Proposed restrictions could curtail or complicate collaborations with certain foreign countries or entities.
Those effects concern scientists who say sustained uncertainty and added bureaucratic burdens could push researchers away from federally funded projects or impede collaborations essential to many fields.
Foreign collaboration clause could complicate international research
The OMB draft includes language that would bar use of funds "to support a bilateral or multilateral collaboration, agreement, program, or activity with a covered foreign country or covered foreign entity." The proposal does not define implementation details in the material released, but even as written it could create significant obstacles for cross-border work.
| Policy change | Potential impact |
|---|---|
| Evaluation against presidential priorities | Scientific merit could be subordinated to political objectives |
| Political appointee oversight of awards | Peer review authority diminished; increased appeal and delay risk |
| Prohibition on certain foreign collaborations | Cross-border projects on topics like cancer or environmental health could face barriers |
The source material notes the possibility that such a ban, depending on its interpretation and implementation, "could create formidable obstacles to collaborations between US and (eg) Chinese scientists on scientific projects related to topics such as cancer, environmental health, or new technologies."
Observers characterize the pattern — funding disruptions, added political reviews, and restrictions on international partnerships — as one that could, over time, make federally supported research so difficult that researchers seek alternatives or stop applying for federal support altogether.
How the rulemaking proceeds and how agencies implement any final changes will determine the scale of the effect on the U.S. research system. For now, the combination of proposed regulation and recent administrative practice has injected fresh uncertainty into a system long governed by peer review and federal support.
